// App-Quantinova.ai

3698 : The effect of epigenetic silencing and p53 mutation on DLL4 expression in human cancer stem cell disorder: The Li-Fraumeni syndrome

Researchers

Presenter

  • Zhixing Yao

Principal Investigators

  • Zaki A. Sherif

Medical Centers

  • Howard University Hospital, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Li-Fraumeni syndrome

  • Breast cancer

  • Brain cancer

  • Solid malignancies

Biomarkers

  • p53

  • Thrombospondin-1

  • Tumor protein p53

  • DNA methylation

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved